Trials / Unknown
UnknownNCT06114979
Silodosin vs Placebo in the Treatment of Female LUTS
Silodosin vs Placebo in the Treatment of Female Lower Urinary Tract Symptoms: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 278 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This trial will be conducted to study the efficacy and safety of Silodosin in the treatment of female lower urinary tract symptoms.
Detailed description
The double blinded randomized controlled trial will evaluate efficacy and safety of silodosin in treatment of female lower urinary tract symptoms by comparing with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Silodosin | Each patient will receive 8 mg of silodosin tablet once daily. |
| DRUG | Placebo | Each patient will receive placebo tablet. |
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-10-30
- Completion
- 2024-12-30
- First posted
- 2023-11-02
- Last updated
- 2023-11-02
Source: ClinicalTrials.gov record NCT06114979. Inclusion in this directory is not an endorsement.